Icosavax, Inc.
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study of IVX-A12 in Adults Participants (NCT06481579) | Icosavax, Inc. | 2024-06-10 |
| A Study to Evaluate the Safety and Immunogenicity of IVX-A12 in Participants of 60 to 85 Years of Age (NCT05903183) | Icosavax, Inc. | 2023-05-15 |
| Safety and Immunogenicity of IVX-A12 in Healthy Older Adults (NCT05664334) | Icosavax, Inc. | 2022-09-21 |
Track Icosavax, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.